dostarlimab
gsk
['dostarlimab', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'rectal']
this is incredible news for #crc #clinicaltrial showed patients had a complete response on treatment (#dostarlimab). trial shows that mismatch repair deficient, locally advanced #rectalcancer was highly sensitive to single-agent pd-1 blockade.
#asco22 #crcsm 
Our mission is to help ALL cancer patients find & access clinical trials, for free. Check out our award-winning tool and register for updates on https://t.co/1jlWF0GYx8.